Gepotidacin

Overview

Gepotidacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3317856).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Gepotidacin expires 13 Dec 2042 and exclusivity 25 Mar 2035. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(3R)-3-[[4-(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione

Canonical SMILES

C1CC2=CC(=NC=C2OC1)CNC3CCN(CC3)C[C@@H]4CN5C(=O)C=CC6=C5N4C(=O)C=N6

InChIKey

PZFAZQUREQIODZ-LJQANCHMSA-N